A detailed history of Elequin Capital LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Elequin Capital LP holds 29 shares of BMRN stock, worth $1,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Holding current value
$1,932
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $2,001 - $2,721
29 New
29 $2,000
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $8,581 - $9,929
99 New
99 $8,000
Q3 2022

Nov 10, 2022

SELL
$82.16 - $96.94 $12,488 - $14,734
-152 Reduced 63.6%
87 $7,000
Q2 2022

Aug 11, 2022

BUY
$71.48 - $86.85 $3,574 - $4,342
50 Added 26.46%
239 $20,000
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $14,038 - $17,518
189 New
189 $15,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Elequin Capital LP Portfolio

Follow Elequin Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Elequin Capital LP with notifications on news.